Overview

Update
Total Equity Funding
$26.5M in 2 Rounds from 4 Investors
Most Recent Funding
$3M Grant on August 22, 2016
Headquarters:
Caesarea, Hefa
Description:
Dune Medical Devices is engaged in the development and commercialization of intraoperative, real-time, cancer detection devices.
Founders:
Categories:
Medical Device, Health Care, Medical
Website:
http://www.dunemedical.com
Social:

Company Details

Update

Dune Medical Devices was founded in 2002 to realize the extraordinary medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the ability to detect cancer in real time, this technology holds promise for a broad range of diagnostic and therapeutic applications. Surgeons who fight cancer on a daily basis must always contend with the lingering question, “Did I get it all?” It forces those who tackle breast cancer to consistently balance the imperative towards aggressive treatment with the desire to conserve tissue. A critical leveler in that struggle may be MarginProbe™ from Dune Medical. The MarginProbe™ System delivers real-time cancer detection in the OR for a simple and immediate assessment of cancer on the margin of excised tissue. In a randomized study of 300 breast cancer patients in Israel, the reoperation rate was reduced by 56% vs. standard of care when the MarginProbe System was employed.

Funding Rounds (3) - $29.5M

Update
DateAmount / RoundValuationLead InvestorInvestors
Aug, 2016$3M / Grant0
Jun, 2014$14M / Series C4
Jun, 2006$12.5M / Series B1

Current Team (6)

Update

Products (1)

Update
  • The Marginprobe helps surgeons assess clean margins on excised tissue.

Offices/Locations (2)

Update
  • US Office

    43 Leopard Road

    Building 2, Suite 302

    Paoli, Pennsylvania 19301

    United States

  • HQ

    20 Alon Hatavor St., 38900

    Caesarea, Hefa 38900

    Israel

Past Team (5)

Update

Images (1)

Update

Add Acquisitions

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos

Portions of this content provided by